Live feed
Filing
SC 13G
SC 13G0001104659-16-153344·Novartis Bioventures Ltd
Schedule 13G ownership disclosure
Ra Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 74933V108
Event date: 2016-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,545,652
- Percent of class
- 11.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-153344
- Form type
- SC 13G
- Filer
- Novartis Bioventures Ltd
- CIK
- CIK 1297709
- Filed
- Oct 31, 2016
- Reporting period
- Oct 31, 2016
- Description
- Schedule 13G beneficial ownership